Gross Margin - CASI Pharmaceuticals Inc (NASDAQ:CASI) - Alpha Spread
C

CASI Pharmaceuticals Inc
NASDAQ:CASI

Watchlist Manager
CASI Pharmaceuticals Inc
NASDAQ:CASI
Watchlist
Price: 6.54 USD -3.25% Market Closed
Market Cap: 87.6m USD
Have any thoughts about
CASI Pharmaceuticals Inc?
Write Note

Gross Margin
CASI Pharmaceuticals Inc

59.2%
Current
58%
Average
63%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
59.2%
=
Gross Profit
20.1m
/
Revenue
33.9m

Gross Margin Across Competitors

Country US
Market Cap 87.5m USD
Gross Margin
59%
Country US
Market Cap 341.9B USD
Gross Margin
67%
Country US
Market Cap 180.5B USD
Gross Margin
63%
Country US
Market Cap 127.8B USD
Gross Margin
87%
Country US
Market Cap 123.3B USD
Gross Margin
86%
Country US
Market Cap 104.5B USD
Gross Margin
77%
Country US
Market Cap 94.1B EUR
Gross Margin
76%
Country AU
Market Cap 142.3B AUD
Gross Margin
52%
Country US
Market Cap 39.3B EUR
Gross Margin
75%
Country US
Market Cap 38.5B USD
Gross Margin
97%
Country US
Market Cap 35.4B USD
Gross Margin
87%

Profitability Report

View the profitability report to see the full profitability analysis for CASI Pharmaceuticals Inc.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
59.2%
=
Gross Profit
20.1m
/
Revenue
33.9m
What is the Gross Margin of CASI Pharmaceuticals Inc?

Based on CASI Pharmaceuticals Inc's most recent financial statements, the company has Gross Margin of 59.2%.